By getting their tumor genetically tested, a patient may find out that they are eligible for certain treatment options.
At this year's American Society of Clinical Oncology (ASCO) Annual Meeting, we spoke with Sarah DeBord, the communications and project manager at the Colon Cancer Coalition.
Treatment for colorectal cancer is becoming more personalized, so it is important that patients talk to their health care providers about having their tumor tested for genetic modifications such as microsatellite instability-high (MSI-H) status, which will likely be a deciding factor in the treatment that the patient gets.
Music: https://www.bensound.com
The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer
February 16th 2023Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Listen
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Listen